Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preliminary effects of intermittent theta burst stimulation combined with virtual reality-based cycling training on upper extremity function in children with cerebral palsy: a double-blind randomized crossover trial.

BMC neurology·2026
Same author

Taiwan Clinical Practice Guidelines for Myasthenia Gravis.

Acta neurologica Taiwanica·2026
Same author

The association between prescribed hormonal contraception and multiple sclerosis risk: a systematic review and meta-analysis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Fatigue prevalence, interactions with associated symptoms and longitudinal changes in those with multiple sclerosis: Insights from the TONiC study.

Journal of the neurological sciences·2026
Same author

Employment status in people with multiple sclerosis: Profile, dynamic changes and determinants over time.

Multiple sclerosis and related disorders·2025
Same author

Therapeutic challenges in patients with multiple sclerosis and ankylosing spondylitis: A case series.

Multiple sclerosis and related disorders·2025

Related Experiment Video

Updated: May 1, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K

Diagnostic modalities in multiple sclerosis: perspectives in children.

I-Jun Chou, William P Whitehouse, Huei-Shyong Wang1

  • 1Division of Pediatric Neurology, Chang Gung Children's Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan, .

Biomedical Journal
|April 16, 2014
PubMed
Summary

Diagnosing pediatric multiple sclerosis (MS) is challenging due to atypical presentations. This review highlights key differences and novel biomarkers like AQP4 and MOG antibodies to aid early and accurate diagnosis in children.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

3.8K

Related Experiment Videos

Last Updated: May 1, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

3.8K

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Neuroimmunology

Background:

  • Pediatric multiple sclerosis (MS) is rare (2-5% of MS cases) but characterized by higher relapse rates and earlier disability progression compared to adult-onset MS.
  • Early diagnosis is crucial to initiate treatment, reduce neuroinflammation, and prevent irreversible neurodegeneration in children.
  • Differentiating pediatric MS from acute disseminated encephalomyelitis (ADEM) and neuromyelitis optica (NMO) is difficult due to atypical initial presentations.

Purpose of the Study:

  • To review and summarize the critical clinical, neuroimaging, and paraclinical distinctions between pediatric MS, ADEM, and NMO.
  • To discuss the role of emerging biomarkers, including antibodies against aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG), in improving diagnostic accuracy.

Main Methods:

  • Literature review focusing on clinical presentations, neuroimaging findings (MRI), and paraclinical data in pediatric inflammatory demyelinating diseases.
  • Analysis of diagnostic criteria and differentiating features for MS, ADEM, and NMO in the pediatric population.
  • Evaluation of the utility of novel biomarkers, such as anti-AQP4 and anti-MOG antibodies.

Main Results:

  • Pediatric MS, ADEM, and NMO often present atypically, complicating differential diagnosis even with standard clinical and MRI assessments.
  • Specific autoantibodies, particularly anti-AQP4 and anti-MOG, show promise as key discriminators between these conditions.
  • Understanding these differences is vital for appropriate patient management and therapeutic strategies.

Conclusions:

  • Distinguishing pediatric MS from ADEM and NMO requires careful consideration of clinical, imaging, and paraclinical evidence.
  • Novel biomarkers like anti-AQP4 and anti-MOG antibodies are essential tools for enhancing diagnostic precision in pediatric inflammatory demyelinating diseases.
  • Accurate diagnosis facilitates timely intervention, potentially altering the long-term prognosis for children with these conditions.